Crossmark Global Holdings, Inc. - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 433 filers reported holding REPLIGEN CORP in Q3 2022. The put-call ratio across all filers is 0.64 and the average weighting 0.2%.

Quarter-by-quarter ownership
Crossmark Global Holdings, Inc. ownership history of REPLIGEN CORP
ValueSharesWeighting
Q3 2023$640
-13.2%
4,124
-2.5%
0.02%
-6.2%
Q2 2023$737
-4.3%
4,228
-7.6%
0.02%
-11.1%
Q1 2023$770
+3.5%
4,575
+4.1%
0.02%
-5.3%
Q4 2022$744
-99.9%
4,394
+0.8%
0.02%
-17.4%
Q3 2022$815,000
+15.3%
4,357
+0.2%
0.02%
+27.8%
Q2 2022$707,000
-14.4%
4,350
-0.9%
0.02%0.0%
Q1 2022$826,000
-33.9%
4,390
-7.0%
0.02%
-33.3%
Q4 2021$1,250,000
-38.9%
4,720
-33.3%
0.03%
-43.8%
Q3 2021$2,046,000
+37.4%
7,080
-5.1%
0.05%
+37.1%
Q2 2021$1,489,000
-1.9%
7,460
-4.5%
0.04%
-7.9%
Q1 2021$1,518,000
+1.5%
7,810
+0.1%
0.04%0.0%
Q4 2020$1,495,000
+37.7%
7,800
+6.0%
0.04%
+26.7%
Q3 2020$1,086,000
+20.7%
7,360
+1.1%
0.03%
+15.4%
Q2 2020$900,000
+44.9%
7,280
+13.2%
0.03%
+18.2%
Q1 2020$621,000
+3.8%
6,430
-0.6%
0.02%
+37.5%
Q4 2019$598,000
+24.1%
6,470
+2.9%
0.02%
+14.3%
Q3 2019$482,000
-10.9%
6,290
-0.2%
0.01%
-6.7%
Q2 2019$541,000
+41.3%
6,300
-2.8%
0.02%
+36.4%
Q1 2019$383,000
+10.4%
6,480
-1.4%
0.01%0.0%
Q4 2018$347,000
-40.3%
6,570
-37.3%
0.01%
-26.7%
Q3 2018$581,000
+21.8%
10,480
+3.4%
0.02%
+15.4%
Q2 2018$477,000
+35.5%
10,140
+4.2%
0.01%
+44.4%
Q1 2018$352,000
-7.6%
9,730
-7.2%
0.01%0.0%
Q4 2017$381,000
+58.1%
10,490
+66.5%
0.01%
+50.0%
Q3 2017$241,0000.0%6,3000.0%0.01%0.0%
Q3 2016$241,0006,3000.01%
Other shareholders
REPLIGEN CORP shareholders Q3 2022
NameSharesValueWeighting ↓
12 West Capital Management LP 812,225$215,110,0009.54%
Ally Bridge Group (NY) LLC 70,000$18,539,0006.48%
Miura Global Management 90,000$23,836,0004.04%
LRT Capital Management, LLC 16,710$4,425,0003.37%
AWM Investment Company, Inc. 100,000$26,484,0002.66%
Ranger Investment Management 175,179$46,394,0002.53%
Conestoga Capital Advisors, LLC 653,901$173,179,0002.25%
Spouting Rock Asset Management, LLC 10,679$2,828,0002.22%
Brown Capital Management 1,010,115$267,519,0002.21%
Yorktown Management & Research Co Inc 11,050$2,926,0001.98%
View complete list of REPLIGEN CORP shareholders